IL-10 Reporter HEK 293 Cells
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
HEK-Blue™ IL-10 Cells Human IL-10 Reporter Cells |
Show product |
3-7 x 10e6 cells |
hkb-il10
|
|
||
HEK-Blue™ IL-10 vial Additional cell vial |
Show product |
3-7 x 10e6 cells |
hkb-il10-av
|
Notification: Reference #hkb-il10-av can only be ordered together with reference #hkb-il10.
IL-10 Reporter Cells
HEK-Blue™ IL-10 Cells signaling pathway
HEK-Blue™ IL-10 cells were engineered from the human embryonic kidney HEK293 cell line to detect bioactive human interleukin 10 (IL-10) by monitoring the activation of the STAT3 pathway. These cells can also be used for screening anti-IL-10/10R antibodies.
IL-10 is an anti-inflammatory cytokine with a crucial role in preventing inflammatory and autoimmune pathologies [1, 2].
Cell line description:
HEK-Blue™ IL-10 cells were generated by stable transfection of the human embryonic kidney HEK293 cell line with the genes encoding hIL-10R α and β chains, human STAT3, and the STAT3-inducible SEAP (secreted embryonic alkaline phosphatase) reporter.
The binding of IL-10 to its receptor on the surface of HEK-Blue™ IL-10 cells triggers JAK1/STAT3 signaling and the subsequent production of SEAP. This can be readily assessed in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent.
HEK-Blue™ IL-10 cells detect human (h)IL-10 and, to a lesser extent, murine (m) IL-10 (see figures). These cells are not responsive to hIL-1β, hIL-2, hIL-6, hIL-12, hIL-22, hIL-23, hIFN-α, hIFN-β, hIFN-γ, and hTNF-α (see figures).
Key features:
- Fully functional IL-10 signaling pathway
- Readily assessable STAT3-inducible SEAP reporter activity
Applications:
- Detection of hIL-10 and, to a lesser extent, mIL-10
- Screening of anti-IL-10/10R antibodies
References:
1. Saraiva M, et al., 2019. Biology and therapeutic potential of interleukin-10. J. Exp. Med. doi: 10.1084/jem.20190418.
2. Ouyang W & O’Garra A, 2019. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 50:871-91.
Specifications
Antibiotic resistance: Blasticidin, Hygromycin B Gold, Zeocin®
Growth medium: DMEM, 4.5 g/l glucose, 2-4 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™
Guaranteed mycoplasma-free
Specificity: human and mouse IL-10
Detection range:
- 0.3 - 30 ng/ml for human IL-10
- 25 - 1000 ng/ml for murine IL-10
These cells are covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 3-7 x 106 HEK-Blue™ IL-10 cells in a cryovial or shipping flask
- 2 x 1 ml of HEK-Blue™ Selection (250x concentrate)
- 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasma, bacteria, and fungi.
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada and some areas in Asia)
Back to the topDetails
Interleukin 10 (IL-10), is the founding member of the IL-10 cytokine family, which comprises IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28A (IFN-λ2), IL-28B (IFN-λ3), and IL-29 (IFN-λ1)1. IL-10 was originally depicted as a key mediator of anti-inflammatory responses. While the immunosuppressive action of IL-10 is illustrated by its genetic association to inflammatory bowel disease, or its upregulated expression in chronic infections, an unanticipated IL-10 protective role has been reported in cancer [1].
IL-10 also plays important homeostatic roles in non-immune cells, including neurons, adipocytes, and epithelial cells [1]. The manipulation of IL-10 production and signaling has thus become an attractive therapeutic strategy [2].
Upon IL-10 binding, the IL-10Rα chain oligomerizes with the IL-10Rβ chain. This in turn allows the phosphorylation of JAK1 (Janus kinase 1) and TyK2 (Tyrosine kinase 2), and the subsequent activation of STAT3 (Signal transducer and activator of transcription 3) [1]. Importantly, STAT3 is also activated downstream of other cytokine receptors. How the cells trigger distinct and specific gene expression in response to cytokines signaling through the same transcription factor is not fully understood yet [1].
1. Saraiva M, et al., 2019. Biology and therapeutic potential of interleukin-10. J. Exp. Med. doi: 10.1084/jem.20190418.
2. Ouyang W & O’Garra A, 2019. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 50:871-91.